» Articles » PMID: 21437131

Disturbance of Inorganic Phosphate Metabolism in Diabetes Mellitus: Temporary Therapeutic Intervention Trials

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2011 Mar 26
PMID 21437131
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A paradoxical metabolic imbalance in inorganic phosphate occurs from the early onset of diabetes and may lead to a reduction of high energy phosphates and tissue hypoxia. These changes take place in the cells and tissues in which the entry of glucose is not controlled by insulin, and particularly in poorly regulated diabetes patients in whom long-term vascular complications are more likely to occur. Several therapeutic intervention trials have been carried out, including assessment of optimal glucose regulation, the effect of dietary inclusion of calcium diphosphate and pharmaceutical intake of etidronate disodium (EHDP), but none of these modalities wholly overcome the problem. The potential therapeutic application of fructose-1, 6-diphosphate, however, which also acts as human bioenergy, holds a great deal of promise as an efficacious and well-tolerated therapeutic regimen.

Citing Articles

A Review of Current Evidence on the Relationship between Phosphate Metabolism and Metabolic Syndrome.

Wong S Nutrients. 2022; 14(21).

PMID: 36364791 PMC: 9656201. DOI: 10.3390/nu14214525.


Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients-Cardiologists Be Aware.

Kurpas A, Supel K, Wieczorkiewicz P, Bodalska Duleba J, Zielinska M Metabolites. 2022; 12(6).

PMID: 35736431 PMC: 9254740. DOI: 10.3390/metabo12060498.


Prevalence and Correlates of Hypophosphatemia Among Type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and genetics (NCDEG).

Rashed R, Hyassat D, Batieha A, Aldabbas M, Aldarabah F, El-Khateeb M Ann Med Surg (Lond). 2022; 78:103770.

PMID: 35592823 PMC: 9110974. DOI: 10.1016/j.amsu.2022.103770.


Vitamin D with Calcium Supplementation Managing Glycemic Control with HbA1c and Improve Quality of Life in Patients with Diabetes.

Mehta S, Nain P, Agrawal B, Singh R Turk J Pharm Sci. 2022; 19(2):161-167.

PMID: 35509447 PMC: 9083518. DOI: 10.4274/tjps.galenos.2021.62357.


Phosphate and fibroblast growth factor 23 in diabetes.

Van der Vaart A, Yeung S, van Dijk P, Bakker S, de Borst M Clin Sci (Lond). 2021; 135(14):1669-1687.

PMID: 34283205 PMC: 8302806. DOI: 10.1042/CS20201290.


References
1.
Sestoft L . Regulation of fructose metabolism in the perfused rat liver. Interrelation with inorganic phosphate, glucose, ketone body and ethanol metabolism. Biochim Biophys Acta. 1974; 343(1):1-16. DOI: 10.1016/0304-4165(74)90235-9. View

2.
LARDY H, Wellman H . Oxidative phosphorylations; rôle of inorganic phosphate and acceptor systems in control of metabolic rates. J Biol Chem. 1952; 195(1):215-24. View

3.
Ehringer W, Niu W, Chiang B, Wang O, Gordon L, Chien S . Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells. Mol Cell Biochem. 2000; 210(1-2):35-45. DOI: 10.1023/a:1007059214754. View

4.
Christoffersen J, Christoffersen M, Ruben J, Arends J . The effect of EHDP concentration on enamel demineralization in vitro. J Dent Res. 1991; 70(2):123-6. DOI: 10.1177/00220345910700020501. View

5.
Ditzel J, Hau C, Daugaard N . Effect of the diphosphonate ethane-I-hydroxy-I, I-diphosphonate (EHDP) on hemoglobin oxygen affinity of diabetic and healthy subjects. Microvasc Res. 1977; 13(3):355-61. DOI: 10.1016/0026-2862(77)90102-9. View